Perttu T. Arkkila

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Translation and validation of the Rome IV Functional Gastrointestinal Disease questionnaire for adults and prevalence of functional gastrointestinal disorders in the general Finnish population.

Translation and validation of the Rome IV Functional Gastrointestinal Disease questionnaire for adults and prevalence of functional gastrointestinal disorders in the general Finnish population.

Journal: Scandinavian journal of gastroenterology

Published: June 01, 2026

Can the indications for gastroscopy in dyspeptic patients be tightened?

Can the indications for gastroscopy in dyspeptic patients be tightened?

Journal: Scandinavian journal of gastroenterology

Published: April 13, 2026

Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications.

Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications.

Journal: Clinical and experimental gastroenterology

Published: October 28, 2025

Characterization of fecal deglucuronidation activity in healthy subjects and in patients treated with fecal microbiota transplantation.

Characterization of fecal deglucuronidation activity in healthy subjects and in patients treated with fecal microbiota transplantation.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: September 03, 2025

Gastrointestinal bacterial infections precede disease activation and treatment intensification in patients with inflammatory bowel disease.

Gastrointestinal bacterial infections precede disease activation and treatment intensification in patients with inflammatory bowel disease.

Journal: Therapeutic advances in gastroenterology

Published: March 18, 2025

Prolonged effect of antibiotic therapy on the gut microbiota composition, functionality, and antibiotic resistance genes' profiles in healthy stool donors.

Prolonged effect of antibiotic therapy on the gut microbiota composition, functionality, and antibiotic resistance genes' profiles in healthy stool donors.

Journal: Frontiers in microbiology

Published: March 10, 2025

Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis.

Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis.

Journal: Therapeutic advances in gastroenterology

Published: March 10, 2025

Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease.

Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease.

Journal: International journal of colorectal disease

Published: February 03, 2025

Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease.

Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease.

Journal: Digestive diseases and sciences

Published: November 26, 2024

Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial.

Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: July 29, 2024

Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection.

Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection.

Journal: Therapeutic advances in gastroenterology

Published: July 11, 2024

Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease.

Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease.

Journal: European journal of gastroenterology & hepatology

Published: July 08, 2024

Showing 1-12 of 78

Last Updated: 09/26/2026